Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No worries here.
In every basin formed by the stock if you look back in the chart there is a good high-volume candle upward right in the middle it goes back down for a little while and then the real move starts.
Just confirmation of true bottom
On decent volume too for this stock. Definitely indicating bottom. Definitely indicating a reversal. Nothing major, but when we kick the FDA’s ass this shit is going to get crazy.
Does anyone have any idea how long the FDA suit and the SEC investigation should take? Is this going to be something that they figure out quickly or is this going to be a long drawn out court battle that lasts for years?
Reading this article makes me glad I’m not a pussy. When this verdict comes in Truth is going to be a millionaire. And it If it goes the wrong way, guess what, I can afford to lose it. Putting everything on black baby, Go $USRM!
“The best current thinking is that injected stem cells exert a powerful healing effect, secreting proteins that improve blood flow, tamp inflammation, and aid in recovery, says Stanford neurosurgeon and stem cell researcher Gary Steinberg”.
I like that part. Maybe Comella’s got some Back alley PhD, maybe not but there’s a neurosurgeon at Stanford and happens to agree with our position. Hmmmmmmm
“A complaint is merely a set of
allegations that, if the case were to proceed to trial, the government would need to prove by a preponderance of the evidence."
Also...Selective prosecution of a subset of group or population area is a violation of the equal protection clause of the 14th amendment. The judge more than likely should either force the DOJ and FDA to close ALL clinics using adipose stem cells or ask why these two bureaucracies are pushing their weight around on such a small subset of the industry.
ALSO, congress recently passed a law telling the FDA they can not go after a company for strictly guidance (a set of internal procedures that the FDA created) Guidance is not law. The FDA is using guidance docs to go after USRM so theoretically USRM's case is pretty strong. I will say you never know what your going to get with this administration and with the type of money big pharma can throw around but to act like they have less than a 50% chance of winning when literally the law is on their side..is FUD. Not saying they will or wont win but just going off of the law, I like their chances.
And lastly,
TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER L--REGULATIONS UNDER CERTAIN OTHER ACTS ADMINISTERED BY THE FOOD AND DRUG ADMINISTRATION
PART 1271 -- HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS
Subpart A--General Provisions Sec. 1271.15 Are there any exceptions from the requirements of this part?
(a) You are not required to comply with the requirements of this part if you are an establishment that uses HCT/P's solely for nonclinical scientific or educational purposes.
***********(b) You are not required to comply with the requirements of this part if you are an establishment that removes HCT/P's from an individual and implants such HCT/P's into the same individual during the same surgical procedure.
(c) You are not required to comply with the requirements of this part if you are a carrier who accepts, receives, carries, or delivers HCT/P's in the usual course of business as a carrier.
**********(d) You are not required to comply with the requirements of this part if you are an establishment that does not recover, screen, test, process, label, package, or distribute, but only receives or stores HCT/P's solely for implantation, transplantation, infusion, or transfer within your facility.
(e) You are not required to comply with the requirements of this part if you are an establishment that only recovers reproductive cells or tissue and immediately transfers them into a sexually intimate partner of the cell or tissue donor.
(f) You are not required to register or list your HCT/P's independently, but you must comply with all other applicable requirements in this part, if you are an individual under contract, agreement, or other arrangement with a registered establishment and engaged solely in recovering cells or tissues and sending the recovered cells or tissues to the registered establishment.
Love this post on USRM’s Facebook today.
Not me, but I thought it worth sharing.
Hmmmmm......Am I a millionaire yet?
Tick tock
Accumulation distribution line heading north. Chaikin money flow is about to cross the zero line, also heading north. Hmmmmmmmm....... wonder what’s really going on.
For real. Big ass bear flag staring me in the face for days and my dumb as is buying more when I should be holding.
Everyone grab your seats, and try not to let that funky feeling, the one that makes your sphincter clench up, cause you to do something rash.
Obviously a coordinated attack.
Tomb stone Doji yesterday. Confirmation of bottom. Just put up some bid support. Someone please give me those shares at .0495
OKAY! OKAY! Get out there $USRM!
Question: everyone knows I am long. I would like to know, though, why USRM would need to sell unregistered shares for financing if autologous stem cell demand has been drastically increasing over the last few months per the PR.
“Phones ringing off the hook” it was said, I believe.
So, again, Why the hell would we need to dilute.
Just a matter of time friends. Go $USRM
“On April 27, Sanford Health announced that the U.S. Food Drug And Administration has recently approved two new clinical trials involving adipose-derived stem cells to be conducted at its facility.
One of these treatments is the facet joint study, a feasibility trial which has just opened this summer. The testing will look into the probable healing capability of adipose-derived stem cells in patients with osteoarthritis of the facet joints.
The study will be participated by 40 patients — 20 will undergo liposuction and the other 20 will receive standard of treatment care. Thomas Boetel, M.D. is the lead investigator for the study”
http://www.techtimes.com/articles/226368/20180428/golden-bear-jack-nicklaus-undergoes-experimental-stem-cell-treatment.htm
Do not buy on the ask. It’s crazy that some of you guys of been watching the stock and investing in the stock for a year hitting that ask over and over and over only to see the price drop and you won’t see the sense in putting it on the bid to make sure the price doesn’t drop.
Not trying to disrespect you school but that is just totally wrong.
If everyone is always slaps the ask and no one is putting anything on the bid. When volume dries up we take a deeper plunge. Stack that bid up and make sure that the price doesn’t fall
It’s early, but if I was a betting man I would say we will close on a green hammer today. Reversal is imminent, be looking for a confirmation candle on Friday.
BE CALM- OVER SOLD!
The only reason an article like this would be coming out the day of earnings Would be because somebody wants this company. Go USRM!
Go $USRM! Only the brave!
https://www.huffingtonpost.com/timothy-sykes/4-penny-stock-trading-les_b_7983134.html
"The thing about the trading strategies I teach is that it doesn’t matter what kind of a market you’re in. What I do is look for patterns that tell me a stock is about to blow up or crash, and then I bet on it. And, as I said above, I’m right three out of four times. The patterns are that predictable. It doesn’t matter if I’m working in a bull market or a bear market - when the patterns appear, I know I can make a profit."
Here's to an awesome week ahead, GO $USRM!
Looks like Rocket was right. One last shake before we head back up. They’ll. Shake it Monday also if earnings don’t come out till Tuesday. Look at last years chart just before take off.
ONE LAST SHAKE! $USRM ONLY THE BRAVE!
Check these two out bro. I think you’ll like them:
https://www.stocktrader.com/2011/03/24/spot-bull-flag-pattern-stock-chart-profits/
http://stockcharts.com/articles/wyckoff/2015/06/accumulation-phase-absorbing-stock-like-a-sponge.html
And don’t forget this:
https://oracledispatch.com/2018/04/03/theres-potential-breakout-us-stem-cell-inc-otcmktsusrm/
“US Stem Cell Inc (OTCMKTS:USRM) is a stock on the move in a major way. USRM has been trending sharply higher over the past four months, breaking above major moving averages and accelerating on its rounded upward trajectory in what looks like the beginnings of a potential parabolic advance, from a technical perspective. The trend is now facing up to a key technical hurdle: a gap-fill of the large drop last seen down through the $0.08/share level back in June of 2017. That gap has gone unfilled until last month when the level was tested and rejected. Now, shares are pushing back up to test it again as a possible breakout trigger.”
ALL CHARTIST VIEW $USRM’s daily. You know what it is! GLTA
I agree. That breakout I told you would be coming by Tuesday is here! So stoked!
They will try to take it below eight again and then when they can’t it becomes support and we go up, up, up
Here is a good article on bull flags. Please compare to our chart here at USRM.
Stage 4 anyone?
Chart Says we go through eight by Tuesday !
Close
Chart looks great. What an awesome clothes
USRM!
What! What!
SURE BEATS THE LA TIMES:
“As noted above, USRM shares have been warming up and approaching potential red-hot status as the stock moves to test key resistance areas in its recent upward trend. We have been seeing some signs that its core R&D IP narrative has been progressing, powering the move.
“This is a breakthrough for the more than 7 million Americans suffering from psoriasis, and is another example of how a patient’s own stem cells offer healing modalities for autoimmune conditions,” said Dr. Comella. “Although we require additional studies to further develop more extensive protocol in treating patients with this condition, this is a benchmark indicating there is significant reason to believe the use of autologous stem cells is beneficial in combating this disease”
https://oracledispatch.com/2018/04/03/theres-potential-breakout-us-stem-cell-inc-otcmktsusrm/
Thought: This puts fiscal year and first quarter fin drop pretty close together. Don’t know if that means anything.
I totally agree with your statement AH. But noticed we haven’t seen that inverse relationship play out the way it normally does here because everyone is worried that this is turning into a long term correction and they are sitting on their cash.
The market is going to reorganize now and biotech is going to emerge a new leader, but I think some fears have to be allayed before that will happen.
That is not to say that USRM will not continue its steady trend up. When money really gets comfortable again they will note USRM’s performance financially and technically and we Will see big things happen here.
Again: IMO
Fins sorry
The way I see it, not a good time to release fans anyway. So much money is pulling out of the market all together and looking for safe investments. Maybe 10 -15 days would make the difference In how much attention those find actually get. Just my opinion.
Atom. I know you’ve been here so I say respectfully that this is not the status quo. This is actually abnormal. I’ve been with USRM for a while and this is the first time they’ve filed for an extension that I know of.
Additionally, I remember the days last year when the board got sour because there was just no PR. Then all of a sudden good PR after good PR.
The only thing USRM owes their shareholders is to knock it out of the park.
DON’T STOP THREE FEET FROM GOLD!!!!
sorry jumped the gun
Fins are out!